A 150-million rand large-scale clinical trial for a COVID19 vaccine begins in South Africa on today

SAfm — A 150-million rand large-scale clinical trial for a COVID19 vaccine begins in South Africa on today. This has been announced at a virtual media conference hosted by the University of the Witwatersrand. The trial titled "South African Ox1Cov-19 Vaccine VIDA-Trial" is sponsored by the University of Oxford and the Jenner Institute and funded by the South African Medical Research Council and the Bill and Melinda Gates Foundation. The vaccine is made from a weakened version of a common cold virus.